Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD

Blood (2019) 134 (Supplement_1): 4626.

https://doi.org/10.1182/blood-2019-127950

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Armando Santoro, MD, Luca Castagna, MD, Massimo Magagnoli, MD, Stefania Bramanti, MD, Jacopo Mariotti, MD, Rita Mazza, MD, Lucia Morello, MD, Francesca Ricci, MD, Barbara Sarina, MD, Chiara De Philippis, MD, Simona Sica, MD, Marcello Rodari, MD, Martina Sollini, MD, Margarita Kirienko, MD, Laura Giordano, Arturo Chiti, MD, Paolo Corradini, MD, Carmelo Carlo-Stella, MD

Blood (2018) 132 (Supplement 1): 2185.

https://doi.org/10.1182/blood-2018-99-118127

Published: 2018

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Marthe C.J. Roex, MD, Peter van Balen, MD, Lothar Germeroth, PhD, Lois Hageman, Esther van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, PhD, Jaap J. Zwaginga, MD PhD, Liesbeth C. de Wreede, PhD, Hermann Einsele, MD PhD, Hendrik Veelken, MD PhD, Constantijn J.M. Halkes, MD, Inge Jedema, PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2018) 132 (Supplement 1): 119.

https://doi.org/10.1182/blood-2018-99-111749

Published: 2018

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Pediatric Hematologic Malignancies

Gerardo Lopez-Hernandez, MD, Norma Lopez-Santiago, MD, Alberto Olaya-Vargas, MD M.Sc, Martín Pérez-García, MD M.Sc, Rosa María Nideshda Ramírez-Uribe, MD, Haydée del Pilar Salazar-Rosales, MD, Ángeles Del Campo-Martínez, MD, Laura Alejandra Xiqui-Jardines, MD

Blood (2018) 132 (Supplement 1): 5705.

https://doi.org/10.1182/blood-2018-99-115083

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Comparable Survival Outcome with a Faster Engraftment of HSCT from a Haploidentical Donor Compared to Other Donor Types in Pediatric Acquired Aplastic Anemia

Ho Joon Im, MD PhD, Hyery Kim, MD, Sung-Han Kang, MD, Eun Seok Choi, RN., Kyung-Nam Koh, MD PhD, Jong Jin Seo, MD PhD, Young-Uk Cho, MD PhD, Seongsoo Jang, MD PhD, Seog Woon Kwon, MD PhD, Chan-Jeoung Park, MD PhD, Jin Kyung Suh, MD PhD

Blood (2016) 128 (22): 4679.

https://doi.org/10.1182/blood.V128.22.4679.4679

Published: 2016

Journal Articles

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Mariana Nassif Kerbauy, MD, Lucila Nassif Kerbauy, MD, Iracema Esteves, MD PhD, Jairo Jose Nascimento Sobrinho, MD, Jose Mauro Kutner, MD PhD, Morgani Rodrigues, MD, Fabio Pires de Souza Santos, MD, Guilherme Fleury Perini, MD, Luis Fernando Aranha Camargo, MD PhD, Jacyr Pasternak, MD PhD, Juliana Folloni Fernandes, MD, Luiz Fernando Alves Lima Mantovani, MD, Angela Mandelli Venancio, MD, Gabriele Zamperlini Netto, MD, Cinthya Corrêa da Silva, Fabio Rodrigues Kerbauy, MD PhD, Andreza Alice Feitosa Ribeiro, MDPhD, Nelson Hamerschlak, MD PhD

Blood (2016) 128 (22): 2216.

https://doi.org/10.1182/blood.V128.22.2216.2216

Published: 2016

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

Journal Articles

Intrathecal Rituximab for EBV-Associated Post-Transplant Lymphoproliferative Disorder with Central Nervous System Involvement Unresponsive to Intravenous Rituximab-Based Treatments: A Prospective Study

Qifa Liu, MD, Meiqing Wu, Jing Sun, MD, Yu Zhang, MD, Fen Huang, Hongsheng Zhou, Zhiping Fan, Li Xuan, Guopan Yu, Xutao Guo, Min Dai, Ru Feng, MD

Blood (2015) 126 (23): 4352.

https://doi.org/10.1182/blood.V126.23.4352.4352

Published: 2015

Journal Articles

Mesenchymal Stem Cells Vs. Mesenchymal Stem Cells Combined With Cord Blood For Treating Engraftment Failure Following Autologous Hematopoietic Stem Cell Transplantation: A Pilot Prospective Study

YiYing Xiong, Fan Qian, Fen Huang, Yu Zhang, Yu Wang, MD, Xiaoyong Chen, Zhiping Fan, Hongsheng Zhou, Yang Xiao, MD, Xiaojun Xu, Min Dai, PhD, Na Xu, Jing Sun, MD, Peng Xiang, Xiaojun Huang, Qifa Liu, MD

Blood (2013) 122 (21): 3693.

https://doi.org/10.1182/blood.V122.21.3693.3693

Published: 2013

Journal Articles

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

Qifa Liu, M.D., Li Xuan, Yu Zhang, Hongsheng Zhou, Fen Huang, MD, Min Dai, Yonghua Li, Danian Nie, MD, Na Xu, Xutao Guo, M.D., Dongjun Lin, Yang Xiao, MD, Can Liu, Ph.D, Qianli Jiang, Jing Sun, MD

Blood (2013) 122 (21): 702.

https://doi.org/10.1182/blood.V122.21.702.702

Published: 2013

Journal Articles

The Management of EBV-Associated Post-Transplant Lymphoproliferative Disorder with Central Nervous System Involvement After Allogeneic Hematopoietic Stem Cell Transplantation

Meiqing Wu, Yu Zhang, Fen Huang, M.D., Hongsheng Zhou, Zhiping Fan, Guopan Yu, Xutao Guo, Xian Zhang, Ru Feng, M.D., Jing Sun, Qifa Liu, M.D.

Blood (2012) 120 (21): 1959.

https://doi.org/10.1182/blood.V120.21.1959.1959

Published: 2012

Journal Articles

Influence of recipient's Age On the Outcome of HLA-Matched Sibling Transplants in Adult Patients with Severe Aplastic Anemia Who Conditioned with Fludarabine-Based Regimen

SeungHwan Shin, JaeHo Yoon, SeungAh Yahng, SungEun Lee, ByungSik Cho, KiSung Eom, YooJin Kim, Seok Lee, ChangKi Min, Heeje Kim, SeokGoo Cho, DongWook Kim, WooSung Min, ChongWon Park, JongWook Lee

Blood (2012) 120 (21): 1921.

https://doi.org/10.1182/blood.V120.21.1921.1921

Published: 2012

Journal Articles

Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation,

Jun Fang, M.D., Ph.D., Chenghao Hu, M.D., Mei Hong, M.D., Ph.D., Qiuling Wu, M.D., Ph.D., Yong You, M.D., Ph.D., Zhaodong Zhong, M.D., Ph.D., Ran Zhang, M.D., Weiming Li, M.D., Ph.D., Shanjun Song, M.D., Ping Zou, M.D., Ph.D., Yu Hu, M.D., Ph.D., Linghui Xia, M.D.

Blood (2011) 118 (21): 4070.

https://doi.org/10.1182/blood.V118.21.4070.4070

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Children with Myelodysplastic Syndrome: A Report of a Korean Single Center Experience

Jeong A. Park, MD, Ho Joon Im, MD, PhD, Jong Jin Seo, MD, PhD

Blood (2011) 118 (21): 4500.

https://doi.org/10.1182/blood.V118.21.4500.4500

Published: 2011

Journal Articles

Gemcitabine, Fludarabine, and Melphalan (G-FM) as Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Stem Cell Transplantation (Allo-SCT) in Relapsed and Refractory Hodgkin Lymphoma (HL)

Paolo Anderlini, MD, Rima M Saliba, PhD, Celina Ledesma, B.S., Christina M Chancoco, Sandra Acholonu, Rosamar Valverde, Uday R Popat, MD, Chitra M Hosing, MD, Amin M Alousi, MD, Elizabeth J Shpall, MD, Yago Nieto, MD, PhD, Stefan O Ciurea, MD, Issa Khouri, MD, Richard Champlin, MD

Blood (2011) 118 (21): 3003.

https://doi.org/10.1182/blood.V118.21.3003.3003

Published: 2011

Journal Articles

Defibrotide Low-Dose Continuous Infusion After Allogeneic Stem Cell Transplantation as Prophylaxis for Veno-Occlusive Disease of the Liver.

Alessandro Bonini, Annalisa Imovilli, Angelo Ghirarduzzi, Mauro Silingardi, MD, Annalisa Pilia, Luigi Gugliotta, MD, Francesco Merli

Blood (2010) 116 (21): 3483.

https://doi.org/10.1182/blood.V116.21.3483.3483

Published: 2010

Journal Articles

Favorable Results After GCSF-Primed Allogeneic BMT for Children with Severe Aplastic Anemia Using Busulfan, Cyclophosphamide and ATG as Conditioning Regimen and Cyclosporine-A and Micofenolate Mofetil as Graft-Versus-Host-Disease Prophylaxys: Rapid Engraftment, Low Incidence of Chronic Gvhd and Reduced Graft Rejection Rates.

Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, Rodolfo Calixto, Alexandre Sucupira, Manuela Gomes, Rodrigo Florencio, MD, Monique Martins, ANA Patricia Souto Maior

Blood (2010) 116 (21): 3489.

https://doi.org/10.1182/blood.V116.21.3489.3489

Published: 2010

Journal Articles

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

Pim L.J. van der Heiden, MD, Jessica C. Harskamp, Esther H.M. van Egmond, Piëtte P. Deutz-Terlouw, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 834.

https://doi.org/10.1182/blood.V116.21.834.834

Published: 2010

NARROW

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Pediatric Hematologic Malignancies

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Comparable Survival Outcome with a Faster Engraftment of HSCT from a Haploidentical Donor Compared to Other Donor Types in Pediatric Acquired Aplastic Anemia

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Intrathecal Rituximab for EBV-Associated Post-Transplant Lymphoproliferative Disorder with Central Nervous System Involvement Unresponsive to Intravenous Rituximab-Based Treatments: A Prospective Study

Mesenchymal Stem Cells Vs. Mesenchymal Stem Cells Combined With Cord Blood For Treating Engraftment Failure Following Autologous Hematopoietic Stem Cell Transplantation: A Pilot Prospective Study

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

The Management of EBV-Associated Post-Transplant Lymphoproliferative Disorder with Central Nervous System Involvement After Allogeneic Hematopoietic Stem Cell Transplantation

Influence of recipient's Age On the Outcome of HLA-Matched Sibling Transplants in Adult Patients with Severe Aplastic Anemia Who Conditioned with Fludarabine-Based Regimen

Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation,

Allogeneic Hematopoietic Stem Cell Transplantation for Children with Myelodysplastic Syndrome: A Report of a Korean Single Center Experience

Gemcitabine, Fludarabine, and Melphalan (G-FM) as Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Stem Cell Transplantation (Allo-SCT) in Relapsed and Refractory Hodgkin Lymphoma (HL)

Defibrotide Low-Dose Continuous Infusion After Allogeneic Stem Cell Transplantation as Prophylaxis for Veno-Occlusive Disease of the Liver.

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only